•
Dec 31, 2021

Avidity Biosciences Q4 2021 Earnings Report

Total Revenue
$1.85M
Previous year: $2.14M
-13.5%
EPS
-$0.82
Previous year: -$0.43
+90.7%
Gross Profit
$1.64M
Previous year: -$11.5M
-114.3%
Cash and Equivalents
$320M
Previous year: $321M
-0.3%
Free Cash Flow
-$27.9M
Previous year: -$13.3M
+109.8%
Total Assets
$428M
Previous year: $334M
+28.1%

Avidity Biosciences

Avidity Biosciences